<SEC-DOCUMENT>0001640334-25-000018.txt : 20250106
<SEC-HEADER>0001640334-25-000018.hdr.sgml : 20250106
<ACCEPTANCE-DATETIME>20250106145737
ACCESSION NUMBER:		0001640334-25-000018
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250106
DATE AS OF CHANGE:		20250106
EFFECTIVENESS DATE:		20250106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexaria Bioscience Corp.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284144
		FILM NUMBER:		25510636

	BUSINESS ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7
		BUSINESS PHONE:		250-765-6424

	MAIL ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXARIA CORP.
		DATE OF NAME CHANGE:	20080229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>lxrp_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<html><head><title>lxrp_s8.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As filed with the Securities and Exchange Commission on January 6, 2025</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Registration No. 333-</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">FORM S-8</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:99%;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong><font style="font-size:18pt">LEXARIA BIOSCIENCE CORP.</font></strong></p></td></tr> <tr style="height:15px"> <td style="width:99%;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>(Exact name of registrant as specified in its charter)</strong></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Nevada</strong></p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>20-2000871</strong></p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">(State or other jurisdiction of</p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">incorporation or organization)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">(I.R.S. Employer</p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">Identification No.)</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>100 - 740 McCurdy Road</strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Kelowna, British Columbia</strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Canada</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>V1X 2P7</strong></p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">(Address of Principal Executive Offices)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">(Zip Code)</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>Equity Incentive Plan</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Full title of the plan)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Richard Christopher</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Chief Executive Officer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>#100 &#8211; 740 McCurdy Road</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>Kelowna, British Columbia VIX 2P7</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Name and address of agent for service)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>1-250-765-6424</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Telephone number, including area code, of agent for service)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><em>Copies to:</em></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Gregory Sichenzia, Esq.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Avital Perlman, Esq.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Sichenzia Ross Ference Carmel LLP</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>1185 Avenue of the Americas, 31<sup style="vertical-align:super">st</sup>&nbsp;Floor</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>New York, NY 10036</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Telephone: (212) 930-9700</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="width:30%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Large accelerated filer</p></td> <td style="width:20%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&#9744;</p></td> <td style="width:30%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Accelerated filer</p></td> <td style="width:20%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&#9744;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Non-accelerated filer</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&#9746;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Smaller reporting company</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&#9746;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Emerging growth company</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&#9744;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act&nbsp;&#9744;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EXPLANATORY NOTE</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This registration statement on Form S-8 (the &#8220;Registration Statement&#8221;) relates to an additional 707,715 shares of common stock, par value $0.001 per share of Lexaria Bioscience Corp. (the &#8220;Registrant,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;), which are issuable pursuant to awards that may be granted under our Equity Incentive Plan, as amended (the &#8220;Plan&#8221;). These additional shares have become reserved for issuance as a result of the operation of the &#8220;evergreen&#8221; provision in the Plan. Under the Plan, a total of 1,745,259 shares of common stock have been reserved for issuance upon the grant of awards and exercise of options to directors, officers, employees and consultants of the Company and of the Company&#8217;s affiliates, of which 1,037,544 shares have been registered pursuant to the Registrant&#8217;s previously filed Registration Statement on Form S-8 (File No. 333-276584), filed with the Securities and Exchange Commission, or SEC, on January 18, 2024, Form S-8 (File No. 333-258308), filed with the Securities and Exchange Commission, or SEC, on July 30, 2021, and Form S-8 (File No. 333-231585), filed with the SEC on May 17, 2019 (collectively, the &#8220;Prior Registration Statements&#8221;). Pursuant to General Instruction E to Form S-8, the contents of the Registrant's Prior Registration Statements are incorporated herein by reference except to the extent supplemented, amended or superseded by the information set forth herein. Only those items of Form S-8 containing new information not contained in the earlier registration statement are presented herein. Only those items of Form S-8 containing new information not contained in the Prior Registration Statements are presented herein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This Registration Statement also includes a reoffer prospectus pursuant to Form S-3 (in accordance with Section C of the General Instructions to the Form S-8), which covers reoffers and resales of &#8220;restricted securities&#8221; and/or &#8220;control securities&#8221; (as such terms are defined in Section C of the General Instructions to Form S-8). This reoffer prospectus relates to offers and resales by directors and executive officers of shares of common stock and shares of common stock that are issuable upon the exercise of awards granted by the Company pursuant to the Plan. This reoffer prospectus may be used by the Selling Stockholders for reoffers and resales on a continuous or delayed basis in the future shares of common stock issued pursuant to the Plan.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PART I</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 1.</strong> <strong>Plan Information</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The documents containing the information specified in Part I, and the Note to Part I of Form S-8 will be delivered to each of the participants in accordance with Rule 428 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), but these documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a Prospectus that meets the requirements of Section 10(a) of the Securities Act.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 2. Registrant Information and Employee Plan Annual Information.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Upon written or oral request, any of the documents incorporated by reference in Item 3 of Part II of this Registration Statement (which documents are incorporated by reference in this Section 10(a) Prospectus) and other documents required to be delivered to eligible employers, non-employee directors and consultants pursuant to Rule 428(b) are available without charge by contacting: Vanessa Carle, Head of Legal Department, Lexaria Bioscience Corp., 100 &#8211; 740 McCurdy Road, Kelowna, BC Canada V1X 2P7 at vcarle@lexariabioscience.com or 250-765-6424 ext. 203.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>REOFFER PROSPECTUS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>821,002 Shares</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This reoffer prospectus relates to the public resale, from time to time, of an aggregate of 821,002 shares (the &#8220;Shares&#8221;) of our common stock, $0.001 par value per share, by certain security holders identified herein in the section entitled &#8220;Selling Stockholders&#8221;. The amount of Shares to be reoffered or resold by means of this prospectus by each Selling Stockholder, and any other person with whom such Selling Stockholder is acting in concert for the purpose of selling our securities, may not exceed, during any three-month period, the amount specified in Rule 144(e) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Such Shares have been or may be acquired in connection with awards granted under the Equity Incentive Plan (the &#8220;Plan&#8221;) of Lexaria Bioscience Corp. (the &#8220;Company&#8221;). You should read this prospectus carefully before you invest in the common stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Such resales shall take place on the Nasdaq Capital Market, or such other stock market or exchange on which our common stock may be listed or quoted, in negotiated transactions or otherwise, at market prices prevailing at the time of the sale or at prices otherwise negotiated (see &#8220;Plan of Distribution&#8221; starting on page 9 of this prospectus). We will receive no part of the proceeds from sales made under this reoffer prospectus. The Selling Stockholders will bear all sales commissions and similar expenses. Any other expenses incurred by us in connection with the registration and offering and not borne by the Selling Stockholders will be borne by us.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This reoffer prospectus has been prepared for the purposes of registering the Shares under the Securities Act to allow for future sales by the Selling Stockholders on a continuous or delayed basis to the public without restriction. We have not entered into any underwriting arrangements in connection with the sale of the Shares covered by this reoffer prospectus. The Selling Stockholders identified in this reoffer prospectus, or their pledgees, donees, transferees or other successors-in-interest, may offer the Shares covered by this reoffer prospectus from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our common stock and tradable warrants are listed on the Nasdaq Capital Market under the symbols &#8220;LEXX&#8221; and &#8220;LEXXW,&#8221; respectively, and the last reported sale prices of our common stock and warrants on January 3, 2025 was $2.29 and $0.7999, respectively.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>Investment in our common stock involves a high degree of risk. See &#8220;Risk Factors&#8221; contained in this prospectus on page 8, in our periodic reports filed from time to time with the Securities and Exchange Commission (the &#8220;SEC&#8221;), which are incorporated by reference in this prospectus, and in any applicable prospectus supplement. You should carefully read this prospectus and the documents we incorporate by reference, before you invest in our common stock. </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus. Any representation to the contrary is a criminal offense</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The date of this Prospectus is January 6, 2025</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="TOC">TABLE OF CONTENTS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"></td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Page</strong></p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#SNR">Special Note Regarding Forward-Looking Statements</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">6</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#PS">Prospectus Summary</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">7</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#RF">Risk Factors</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">8</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#UOP">Use of Proceeds</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">8</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#SS">Selling Stockholders</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">8</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#POD">Plan of Distribution</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">9</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#LM">Legal Matters</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">10</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#EX">Experts</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">10</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IDR">Incorporation of Documents by Reference</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">11</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#DOC">Disclosure of Commission Position on Indemnification for Securities Act Liabilities</a></p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">12</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="SNR">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This prospectus, and any documents we incorporate by reference, contain certain forward-looking statements that involve substantial risks and uncertainties. All statements contained in this prospectus and any documents we incorporate by reference, other than statements of historical facts, are forward-looking statements including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The words &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;plan&#8221;, &#8220;predict&#8221;, &#8220;project&#8221;, &#8220;target&#8221;, &#8220;potential&#8221;, &#8220;will&#8221;, &#8220;would&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;continue&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about: the status, progress and results of our research programs; our ability to obtain regulatory approvals for, and the level of market opportunity for, our product candidates; our business plans, strategies and objectives, including plans to pursue collaboration, licensing or other similar arrangements or transactions; our expectations regarding our liquidity and performance, including our expense levels, sources of capital and ability to maintain our operations as a going concern; the competitive landscape of our industry; and general market, economic and political conditions.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">These forward-looking statements are only predictions and we may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, so you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. We have included important factors in the cautionary statements included in this prospectus that could cause actual future results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">You should read this prospectus with the understanding that our actual future results may be materially different from what we expect. We do not assume any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="PS">PROSPECTUS SUMMARY</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><em>This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information that you should consider before deciding to invest in our securities. You should read this entire prospectus carefully, including the &#8220;Risk Factors&#8221; section in this prospectus and under similar captions in the documents incorporated by reference into this prospectus. In this prospectus, unless otherwise stated or the context otherwise requires, references to &#8220;Lexaria,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or similar references mean Lexaria Bioscience Corp. and/or our subsidiaries on a consolidated basis.</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Company Overview</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Lexaria Bioscience Corp. is a biotechnology company dedicated to the enhancement of the bioavailability of a broad range of active pharmaceutical ingredients (&#8220;APIs&#8221;) using our patented DehydraTECH<sup style="vertical-align:super">TM</sup> drug delivery-enabling platform technology. DehydraTECH combines APIs with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">DehydraTECH can be used with a wide range of active molecules including glucagon-like peptide-1 drugs (&#8220;GLP-1&#8221;) and glucose -dependent insulinotropic polypeptide drugs (&#8220;GIP&#8221;), vitamins, pain medications, hormones, phosphodiesterase type 5 (&#8220;PDE5&#8221;) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Our technology can be applied to a variety of therapeutic indications, including diabetes, weight loss, hypertension and heart disease. DehydraTECH can be implemented in a multitude of ingestible or topically administered product formats including oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches. It is suitable for use with a variety of product formats including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">DehydraTECH is a technology incorporated into the formulation and manufacturing process of new or existing orally ingestible and topical products. The procedure involves combining the active ingredient as a delivery &#8220;payload&#8221; together with certain long chain fatty acid-rich triglyceride oils and infusing the mixture into a carrier substrate material. Using controlled dehydration processing, the payload and long chain fatty acid-rich triglyceride oils are reversibly associated together at a molecular level. The newly combined molecules are then integrated into production of the end-product using any number of dosage formats. While the Company&#8217;s primary focus is on pharmaceutical drug products, this technology extends across many product categories including foods, beverages, cosmetics and nutraceuticals. DehydraTECH formulations have been found in some cases to reduce the need for unwanted sweeteners or chemical masking agents used for flavor- and odor-blocking for palatability enhancement purposes, allowing manufacturers to create low-sugar products with fewer calories and artificial sweeteners.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company has developed extensive experience from the formulation and production of its demonstration products, in various formats, that enables it to provide expert advice to our licensees on the integration of DehydraTECH in their products for the purpose of providing more palatable and efficient delivery of bioactive molecules. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Lexaria supports our licensee&#8217;s products with our technology. A part of our business plan is to encourage new and existing industry participants to license and utilize DehydraTECH to enable enhanced performance of their developmental and commercial stage products. These products cross a wide range of bioactive molecules including GLP-1/GIPs, NSAID&#8217;s, nicotine and cannabidiol (&#8220;CBD&#8221;) with additional molecules of interest continually being evaluated.&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Corporate Information</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our principal executive offices are located at 100 &#8211; 740 McCurdy Road, Kelowna, British Columbia, Canada, V1X 2P7. Our telephone number is 1-250-765-6424. We maintain a website at&nbsp;<u>www.lexariabioscience.com</u>. The information contained on our website is not, and should not be interpreted to be, a part of this prospectus. Lexaria Bioscience Corp. is a British Columbia based reporting issuer in Canada and as such, we are required to file certain information and documents at&nbsp;<u>www.sedarplus.ca</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="RF">RISK FACTORS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">An investment in our common stock involves risks. Prior to making a decision about investing in our common stock, you should consider carefully all of the information contained or incorporated by reference in this prospectus, including any risks in the section entitled &#8220;Risk Factors&#8221; contained in any supplements to this prospectus and in our Annual Report on Form 10-K for the fiscal year ended August 31, 2024, and in our subsequent filings with the SEC. Each of the referenced risks and uncertainties could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities. Additional risks not known to us or that we believe are immaterial may also adversely affect our business, operating results and financial condition and the value of an investment in our securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="UOP">USE OF PROCEEDS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Shares which may be sold under this reoffer prospectus will be sold for the respective accounts of each of the Selling Stockholders listed herein (which includes our officers and directors). Accordingly, we will not realize any proceeds from the sale of the Shares. We will receive proceeds from the exercise of the options; however, no assurance can be given as to when or if any or all of the options will be exercised. If any options are exercised, the proceeds derived therefrom will be used for working capital and general corporate purposes. All expenses of the registration of the Shares will be paid by us. See &#8220;Selling Stockholders&#8221; and &#8220;Plan of Distribution.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="SS">SELLING STOCKHOLDERS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are registering for resale the Shares covered by this reoffer prospectus to permit the Selling Stockholders identified below and their pledgees, donees, transferees and other successors-in-interest that receive their securities from a Selling Stockholder as a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the Shares when and as they deem appropriate. The Selling Stockholders may acquire these Shares from us pursuant to the Plan. The Shares may not be sold or otherwise transferred by the Selling Stockholders unless and until the applicable awards vest and are exercised, as applicable, in accordance with the terms and conditions of the Plan.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table sets forth:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">the name of each Selling Stockholder;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">the number and percentage of shares of our common stock that each Selling Stockholder beneficially owned as of January 6, 2025 prior to the offering for resale of the Shares under this prospectus;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">the number of Shares that may be offered for resale for the account of each Selling Stockholder under this prospectus; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">the number and percentage of shares of our common stock to be beneficially owned by each Selling Stockholder after the offering of the resale Shares (assuming all of the offered resale Shares are sold by such Selling Stockholder).</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Information with respect to beneficial ownership is based upon information obtained from the Selling Stockholders. Because the Selling Stockholders may offer all or part of the Shares, which they own pursuant to the offering contemplated by this reoffer prospectus, and because its offering is not being underwritten on a firm commitment basis, no estimate can be given as to the amount of Shares that will be held upon termination of this offering.&nbsp; Except where indicated, all options, restricted stock awards and warrants held by the Selling Stockholders are exercisable within 60 days of January 6, 2025.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The number of shares in the column &#8220;Number of Shares Being Offered Hereby&#8221; represents all of the Shares of our common stock that each Selling Stockholder may offer under this prospectus. We do not know how long the Selling Stockholders will hold the Shares before selling them or how many Shares they will sell. The Shares of our common stock offered by this prospectus may be offered from time to time by the Selling Stockholders listed below. We cannot assure you that any of the Selling Stockholders will offer for sale or sell any or all of the Shares of common stock offered by them by this prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name of Selling Stockholder</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Number of Shares Beneficially Owned Prior to the Offering </strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Number of Shares Being Offered Hereby <sup style="vertical-align:super">(1)</sup></strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Number of Shares Beneficially Owned Upon Completion of the&nbsp;Offering&nbsp;</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Percentage of Shares Beneficially Owned Upon Completion of the Offering <sup style="vertical-align:super">(2)</sup></strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">John Docherty</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">228,243</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">174,168</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">54,075</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2" style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">*</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Christopher Bunka</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">708,456</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">173,834</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">534,622</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><sup style="vertical-align:super">(3)</sup></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">3.03</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Catherine C. Turkel</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">30,100</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">27,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">3,100</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Vanessa Carle</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">60,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">60,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">-</p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">William (Ted) McKechnie</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">65,191</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">52,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">13,191</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Nicholas Baxter</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">63,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">52,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">11,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Albert Reese Jr.</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">42,917</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">32,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">10,917</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Richard Christopher</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">200,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">200,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">-</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><sup style="vertical-align:super">(4)</sup></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Michael Shankman</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">50,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">50,000</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">-</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><sup style="vertical-align:super">(5)</sup></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px"><strong>*</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>TOTAL</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">1,547,907</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">821,002</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">626,905</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:right;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">____________&nbsp; </p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">*</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Less than one percent.</p></td></tr></table> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Reflects 100% of the options issued to each insider under the Plan.&nbsp; </p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">(2)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Based on 17,452,594 shares of common stock issued and outstanding as of January 6, 2025.</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">(3)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Includes 6,667 share purchase warrants for the purchase of 6,667 shares of common stock </p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">(4)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Only 50,000 of the 200,000 Shares issuable upon option exercise are exercisable within 60 days of the filing of this S-8 Registration Statement </p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">(5)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Only 20,000 of the 50,000 Shares issuable upon option exercise are exercisable within 60 days of the filing of this S-8 Registration Statement </p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="POD">PLAN OF DISTRIBUTION</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our common stock is quoted on the Nasdaq Capital Market under the symbol &#8220;LEXX.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Selling Stockholders will act independently of us in making decisions with respect to the timing, manner and size of each and any sale.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Selling Stockholders may, from time to time, sell all or a portion of the Shares on any market where our common stock may be listed or quoted (currently the Nasdaq Capital Market), in privately negotiated transactions or otherwise. Such sales may be at fixed prices prevailing at the time of sale, at prices related to the market prices or at negotiated prices. The Shares being offered for resale by this Prospectus may be sold by the Selling Stockholders by one or more of the following methods:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">block trades in which the broker or dealer so engaged will attempt to sell the Shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">purchases by broker or dealer as principal and resale by the broker or dealer for its account pursuant to this prospectus;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">an exchange distribution in accordance with the rules of the applicable exchange;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">ordinary brokerage transactions and transactions in which the broker solicits purchasers;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">privately negotiated transactions;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">market sales (both long and short to the extent permitted under the federal securities laws);</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">at the market to or through market makers or into an existing market for the Shares;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">through transactions in options, swaps or other derivatives (whether exchange listed or otherwise); and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">a combination of any of the aforementioned methods of sale.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Selling Stockholders may from time to time pledge or grant a security interest in some or all of the Shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledge or secured parties may offer and sell the Shares of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under Rule&nbsp;424(b)(3) or any other applicable provision of the Securities Act amending the list of stockholders to include the pledge, transferee or other successors in interest as Selling Stockholders under this prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In effecting sales, brokers and dealers engaged by the Selling Stockholders may arrange for other brokers or dealers to participate. Brokers or dealers may receive commissions or discounts from a Selling Stockholder or, if any of the broker-dealers act as an agent for the purchaser of such Shares, from a purchaser in amounts to be negotiated which are not expected to exceed those customary in the types of transactions involved. Broker-dealers may agree with a Selling Stockholder to sell a specified number of the Shares at a stipulated price per Share. Such an agreement may also require the broker-dealer to purchase as principal any unsold Shares at the price required to fulfill the broker-dealer commitment to the Selling Stockholder if such broker-dealer is unable to sell the Shares on behalf of the Selling Stockholder. Broker-dealers who acquire Shares as principal may thereafter resell the Shares from time to time in transactions which may involve block transactions and sales to and through other broker-dealers, including transactions of the nature described above. Such sales by a broker-dealer could be at prices and on terms then prevailing at the time of sale, at prices related to the then-current market price or in negotiated transactions. In connection with such resales, the broker-dealer may pay to or receive from the purchasers of the Shares commissions as described above.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Selling Stockholders and any broker-dealers or agents that participate with the Selling Stockholders in the sale of the Shares may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with these sales. In that event, any commissions received by the broker-dealers or agents and any profit on the resale of the Shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">From time to time, any of the Selling Stockholders may pledge its Shares pursuant to the margin provisions of customer agreements with brokers. Upon a default by a Selling Stockholder, their broker may offer and sell the pledged Shares from time to time. Upon a sale of the Shares, the Selling Stockholders intend to comply with the Prospectus delivery requirements under the Securities Act by delivering a Prospectus to each purchaser in the transaction. We intend to file any amendments or other necessary documents in compliance with the Securities Act which may be required in the event any of the Selling Stockholders defaults under any customer agreement with brokers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">To the extent required under the Securities Act, a post-effective amendment to this Registration Statement will be filed disclosing the name of any broker-dealers, the number of Shares, the price at which the Shares are to be sold, the commissions paid or discounts or concessions allowed to such broker-dealers, where applicable, that such broker-dealers did not conduct any investigation to verify the information set out or incorporated by reference in this Prospectus and other facts material to the transaction. We and the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations under it, including, without limitation, Rule 10b-5 and, insofar as a Selling Stockholder is a distribution participant and we, under certain circumstances, may be a distribution participant, under Regulation M.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">All of the foregoing may affect the marketability of the common stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any commissions, discounts or other fees payable to brokers or dealers in connection with any sale of the Shares will be borne by the Selling Stockholders, the purchasers participating in such transaction, or both.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any Shares covered by this Prospectus which qualify for sale pursuant to Rule 144 under the Securities Act, as amended, may be sold under Rule 144 rather than pursuant to this Prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="LM">LEGAL MATTERS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The validity of the securities offered by this Prospectus will be passed upon by Sichenzia Ross Ference Carmel, LLP, New York, New York.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="EX">EXPERTS</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The financial statements of Lexaria Bioscience Corp. incorporated in this prospectus by reference to the Annual Report on Form 10-K for the year ended August 31, 2024 have been so incorporated in reliance on the report of MaloneBailey, LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="IDR">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The SEC allows us to &#8220;incorporate by reference&#8221; the information we have filed with it, which means that we can disclose important information to you by referring you to those documents. The information we incorporate by reference is an important part of this Prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file with the SEC pursuant to Sections l3(a), l3(c), 14 or l5(d) of the Exchange Act subsequent to the date of this prospectus and prior to the termination of the offering:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Annual Report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001787/lxrp_10k.htm">Form 10-K</a> for the year ended August 31, 2024, filed on November 26, 2024;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Current Reports on Form 8-K, filed on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001396/lxrp_8k.htm">September 5, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001473/lxrp_8k.htm">October 2, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001537/lxrp_8k.htm">October 16, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001541/lxrp_8k.htm">October 18, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001908/lxrp_8k.htm">December 18, 2024</a> and <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033425000009/lxrp_8k.htm">January 3, 2025</a> (other than any portions thereof deemed furnished and not filed);</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Form <a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000051/lxrp_8a12b.htm">8-A12B</a>, filed on January 11, 2021; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Form <a href="http://www.sec.gov/Archives/edgar/data/1348362/000113707006000235/f8a.htm">8-A12G</a>, filed on July 14, 2006.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">All filings filed by us pursuant to the Exchange Act after the date of the initial filing of this Registration Statement and prior to the effectiveness of such Registration Statement (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) shall also be deemed to be incorporated by reference into the Prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">You should rely only on the information incorporated by reference or provided in this Prospectus. We have not authorized anyone else to provide you with different information. Any statement contained in a document incorporated by reference into this Prospectus will be deemed to be modified or superseded for the purposes of this Prospectus to the extent that a later statement contained in this prospectus or in any other document incorporated by reference into this Prospectus modifies or supersedes the earlier statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this Prospectus. You should not assume that the information in this Prospectus is accurate as of any date other than the date of this Prospectus or the date of the documents incorporated by reference in this Prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We will provide without charge to each person to whom a copy of this Prospectus is delivered, upon written or oral request, a copy of any or all of the reports or documents that have been incorporated by reference in this Prospectus but not delivered with this Prospectus (other than an exhibit to these filings, unless we have specifically incorporated that exhibit by reference in this Prospectus). Any such request should be addressed to us at:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Lexaria Bioscience Corp.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Attn: Corporate Secretary</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100-740 McCurdy Road</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Kelowna, British Columbia, Canada, VIX 2P7</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1-250-765-6424&nbsp; ext. 203</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">You may also access the documents incorporated by reference in this Prospectus through our website at&nbsp;<u>https://ir.lexariabioscience.com/sec-filings</u>. Except for the specific incorporated documents listed above, no information available on or through our website shall be deemed to be incorporated in this Prospectus or the Registration Statement of which it forms a part.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="DOC">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FOR SECURITIES ACT LIABILITIES</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant, the registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>WHERE YOU CAN FIND MORE INFORMATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are subject to the informational requirements of the Exchange Act and in accordance therewith file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of the SEC&#8217;s website is www.sec.gov.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We make available free of charge on or through our website at https://ir.lexariabioscience.com/sec-filings, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with or otherwise furnish it to the SEC.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We have filed with the SEC a Registration Statement under the Securities Act, relating to the offering of these securities. The Registration Statement, including the attached exhibits, contains additional relevant information about us and the securities. This Prospectus does not contain all of the information set forth in the Registration Statement. You can obtain a copy of the Registration Statement for free at www.sec.gov. The Registration Statement and the documents referred to below under &#8220;Incorporation of Certain Information By Reference&#8221; are also available on our website,&nbsp;<u>https://ir.lexariabioscience.com/sec-filings</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have not incorporated by reference into this Prospectus the information on our website, and you should not consider it to be a part of this Prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>821,002 Shares</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="lxrp_s8img1.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COMMON STOCK</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>REOFFER PROSPECTUS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 3. Incorporation of Documents by Reference.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following documents, which have been filed with the SEC, are incorporated herein by reference:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Annual Report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001787/lxrp_10k.htm">Form 10-K</a> for the year ended August 31, 2024, filed on November 26, 2024;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Current Reports on Form 8-K, filed on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001396/lxrp_8k.htm">September 5, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001473/lxrp_8k.htm">October 2, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001537/lxrp_8k.htm">October 16, 2024</a>,&nbsp; <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033424001541/lxrp_8k.htm">October 18, 2024</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033424001908/lxrp_8k.htm">December 18, 2024</a> and <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1348362/000164033425000009/lxrp_8k.htm">January 3, 2025</a> (other than any portions thereof deemed furnished and not filed);</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Form <a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000051/lxrp_8a12b.htm">8-A12B</a>, filed on January 11, 2021; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">our Form <a href="http://www.sec.gov/Archives/edgar/data/1348362/000113707006000235/f8a.htm">8-A12G</a>, filed on July 14, 2006.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this Registration Statement or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We also incorporate by reference any future filings (excluding information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, until we sell all of the securities offered hereby. Information in such future filings, updates and supplements the information provided in this Registration Statement. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">You may request, orally or in writing, a copy of these documents, which will be provided to you at no cost (other than exhibits, unless such exhibits are specifically incorporate by reference), by contacting Vanessa Carle, c/o Lexaria Bioscience Corp., at 100 &#8211; 740 McCurdy Road, Kelowna, BC Canada V1X 2P7. Our telephone number is 1-250-765-6424. Information about us is also available at our website at https://www.lexariabioscience.com/. The information in our website is not a part of this Registration Statement and is not incorporated by reference.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;<strong>Item 4. Description of Securities.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Not applicable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 5. Interests of Named Experts and Counsel.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Not applicable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 6. Indemnification of Directors and Officers.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Nevada Revised Statutes (the &#8220;NRS&#8221;) empower us to indemnify our directors and officers against expenses relating to certain actions, suits or proceedings as provided for therein. In order for such indemnification to be available, the applicable director or officer must not have acted in a manner that constituted a breach of his or her fiduciary duties and involved intentional misconduct, fraud or a knowing violation of law, or must have acted in good faith and reasonably believed that his or her conduct was in, or not opposed to, our best interests. In the event of a criminal action, the applicable director or officer must not have had reasonable cause to believe his or her conduct was unlawful.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Pursuant to our Articles, we may indemnify each of our present and future directors, officers, employees or agents who becomes a party or is threatened to be made a party to any suit or proceeding, whether pending, completed or merely threatened, and whether said suit or proceeding is civil, criminal, administrative, investigative, or otherwise, except an action by or in the right of the Company, by reason of the fact that he is or was a director, officer, employee, or agent of the Company, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses, including, but not limited to, attorneys&#8217; fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit, proceeding or settlement, provided such person acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interest of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The expenses of directors, officers, employees or agents of the Company incurred in defending a civil or criminal action, suit, or proceeding may be paid by the Company as they are incurred and in advance of the final disposition of the action, suit, or proceeding, if and only if the director, officer, employee or agent undertakes to repay said expenses to the Company if it is ultimately determined by a court of competent jurisdiction, after exhaustion of all appeals therefrom, that he/she is not entitled to be indemnified by the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">No indemnification shall be applied, and any advancement of expenses to or on behalf of any director, officer, employee or agent must be returned to the Company, if a final adjudication establishes that the person&#8217;s acts or omissions involved a breach of any fiduciary duties, where applicable, intentional misconduct, fraud or a knowing violation of the law which was material to the cause of action.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The NRS further provides that a corporation may purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise for any liability asserted against him and liability and expenses incurred by him in his capacity as a director, officer, employee or agent, or arising out of his status as such, whether or not the corporation has the authority to indemnify him/her against such liability and expenses. We have secured a directors&#8217; and officers&#8217; liability insurance policy. We expect that we will continue to maintain such a policy.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 7. Exemption From Registration Claimed.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The grant of our securities were issued as compensation awards or as enticement or incentive awards. These grants were exempt from registration pursuant to Section 4(2) of the Securities Act</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 8. Exhibits</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following exhibits are filed as part of this Registration Statement:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><strong>Number</strong></p></td> <td style="width:1%;"></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><strong>Description</strong></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex11.htm">1.1</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex11.htm">Engagement Agreement with H.C. Wainwright &amp; Co. LLC (incorporated by reference as Exhibit 1.1 to our Current Report on Form 8-K filed October 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex31.htm">3.1</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex31.htm">Amended and Restated Articles of Incorporation (incorporated by reference as Exhibit 3.1 to our Current Report Form 8-K filed January 14, 2021)</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex32.htm">3.2</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex32.htm">Second Amended and Restated Bylaws (incorporated by reference as Exhibit 3.2 to our Current Report on Form 8-K filed January 14, 2021)</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000086/lxrp_ex41.htm">4.1</a></p></td> <td></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000086/lxrp_ex41.htm">Lexaria Bioscience Corp. Equity Incentive Plan, as amended (incorporated by reference as Exhibit 4.1 to our Form S-8 Registration Statement filed January 18, 2024)</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex41.htm">4.2</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex41.htm">Form of Warrant (incorporated by reference as Exhibit 4.1 to our Current Report on Form 8-K filed January 14, 2021)</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex42.htm">4.3</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033421000109/lxrp_ex42.htm">Form of Representative&#8217;s Warrant (incorporated by reference as Exhibit 4.2 to our Current Report on Form 8-K filed January 14, 2021)</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033423000723/lxrp_ex45.htm">4.5</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033423000723/lxrp_ex45.htm">Form of Warrant (incorporated by reference to Exhibit 4.5 to our Registration Statement on Form S-1 filed April 28, 2023)</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex41.htm">4.6</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex41.htm">Form of Pre-Funded Warrant (incorporated by reference as Exhibit 4.1 to our Current Report on Form 8-K filed February 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex42.htm">4.7</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex42.htm">Form of Warrant (incorporated by reference as Exhibit 4.2 to our Current Report on Form 8-K filed February 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex43.htm">4.8</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_ex43.htm">Form of Placement Agent Warrant (incorporated by reference as Exhibit 4.3 to our Current Report on Form 8-K filed February 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex41.htm">4.9</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex41.htm">Form of Warrant (incorporated by reference as Exhibit 4.1 to our Current Report on Form 8-K filed October 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex42.htm">4.10</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_ex42.htm">Form of Placement Agent Warrant (incorporated by reference as Exhibit 4.2 to our Current Report on Form 8-K filed October 16, 2024</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex51.htm">5.1</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex51.htm">Opinion of Sichenzia Ross Ference Carmel LLP</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex51.htm">23.1</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex51.htm">Consent of Sichenzia Ross Ference Carmel LLP (included in the Opinion filed as Exhibit 5.1)</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex232.htm">23.2</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex232.htm">Consent of MaloneBailey, LLP</a></p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="#POWERSOFATTORNEY">24.1</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="#POWERSOFATTORNEY">Powers of Attorney (included on the signature pages to this Registration Statement)</a></p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex107.htm">107</a></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><a href="lxrp_ex107.htm">Filing Fee Table</a></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td><em><a href="#TOC">Table of Contents</a></em></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in Kelowna, British Columbia, on the 6th of January, 2025.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><strong>LEXARIA BIOSCIENCE CORP.</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:50%;"></td> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td style="width:12%;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px"><em>/s/ Richard Christopher</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Richard Christopher</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><a name="POWERSOFATTORNEY">POWERS OF ATTORNEY</a></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Richard Christopher their true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments, to this Registration Statement on Form S-8, and to file the same, with exhibits thereto and other documents in connection therewith, with the SEC granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact and agent, or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Position</strong></p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:24%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Date</strong></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Richard Christopher</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Richard Christopher</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Chief Executive Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">(Principal Executive Officer)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Michael Shankman</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Michael Shankman</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Financial Officer)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/John Docherty</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">John Docherty</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">President &amp; Director </p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em><u>/s/ Christopher Bunka</u></em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Christopher Bunka</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chairman &amp; Director</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6. 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/Ted McKechnie</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Ted McKechnie</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Director </p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/Nicholas Baxter</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Nicholas Baxter</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/Albert Reese Jr.</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Albert Reese Jr.</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">January 6, 2025</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/Catherine C. Turkel</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Dr. Catherine C. Turkel</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;January 6, 2025</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>lxrp_ex51.htm
<DESCRIPTION>OPINION OF SICHENZIA
<TEXT>
<html><head><title>lxrp_ex51.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 5.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_s8img2.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">January 6, 2025</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria Bioscience Corp.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">100 &#8211; 740 McCurdy Road</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Kelowna, BC Canada V1X 2P7</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Re:&nbsp;<strong>Form S-8 Registration Statement</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ladies and Gentlemen:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We refer to the above-captioned registration statement on Form S-8 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), filed by Lexaria Bioscience Corp., a Nevada corporation (the &#8220;Company&#8221;), with the Securities and Exchange Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have examined the originals, photocopies, certified copies or other evidence of such records of the Company, certificates of officers of the Company and public officials, and other documents as we have deemed relevant and necessary as a basis for the opinion hereinafter expressed. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as certified copies or photocopies and the authenticity of the originals of such latter documents.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Based on our examination mentioned above, we are of the opinion that the securities being registered to be sold pursuant to the Registration Statement are duly authorized and will be, when sold in the manner described in the Registration Statement, legally and validly issued, and fully paid and non-assessable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations of the Securities and Exchange Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:3%;"></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Very truly yours,</p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Sichenzia Ross Ference Carmel LLP</em></p></td> <td></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">SICHENZIA ROSS FERENCE CARMEL LLP</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036 </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>lxrp_ex232.htm
<DESCRIPTION>CONSENT OF MALONEBAILEY, LLP
<TEXT>
<html><head><title>lxrp_ex232.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 23.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated November 26, 2024 with respect to the audited consolidated financial statements of Lexaria Bioscience Corp. for the year ended August 31, 2024.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">We also consent to the references to us under the heading &#8220;Experts&#8221; in such Registration Statement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em></em>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ MaloneBailey, LLP</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">www.malonebailey.com</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Houston, Texas</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 6, 2025</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>lxrp_ex107.htm
<DESCRIPTION>FEE TABLE
<TEXT>
<html><head><title>lxrp_ex107.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 107</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Calculation of Filing Fee Table</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM S-8</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Form Type)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact Name of Registrant As Specified in its Charter)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><u>Table 1: Newly Registered Securities</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Security</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Type</strong></p></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Security</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Class</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title</strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Calculation</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Rule</strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Registered <sup style="vertical-align:super">(1)</sup></strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Proposed Maximum</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Offering</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Per Share</strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Maximum</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Offering</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee Rate</strong></p></td> <td></td> <td></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount of Registration</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee</strong></p></td> <td></td></tr> <tr style="height:15px"> <td colspan="27" style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Newly Registered Securities</strong></p></td> <td></td> <td></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fees to Be Paid</strong></p></td> <td style="width:1%;"></td> <td style="width:5%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Equity</p></td> <td style="width:1%;"></td> <td style="width:12%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Common Stock</p></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:12%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">457(c) and (h)</p></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:7%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">707,715<sup style="vertical-align:super">(2)</sup></p></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="width:7%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.12<sup style="vertical-align:super">(3)</sup></p></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="width:7%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,500,355.80</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:7%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0001531</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:7%;vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">229.71</p></td> <td style="width:1%;"></td></tr> <tr style="height:15px;background-color:#ffffff"> <td></td> <td colspan="28"></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fees Previously Paid</strong></p></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px;background-color:#ffffff"> <td colspan="17" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Offering Amounts</strong></p></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,500,355.80</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">-</p></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">229.71</p></td> <td></td></tr> <tr style="height:15px;background-color:#cceeff"> <td colspan="17" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Fees Previously Paid</strong></p></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">-</p></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td></tr> <tr style="height:15px;background-color:#ffffff"> <td colspan="17" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Fee Offsets</strong></p></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">-</p></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td></tr> <tr style="height:15px;background-color:#cceeff"> <td colspan="17" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net Fees Due</strong></p></td> <td></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td> <td></td> <td></td> <td></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">-</p></td> <td></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td style="vertical-align:bottom;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">229.71</p></td> <td></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2" style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Represents shares of common stock reserved for future issuance under the Company&#8217;s Equity Incentive Plan, as amended. </p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per share of common stock as reported on the Nasdaq Capital Market on December 31, 2024, as reported on the Nasdaq Capital Market</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>lxrp_s8img2.jpg
<TEXT>
begin 644 lxrp_s8img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !/ +T# 2(  A$! Q$!_\0
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MOT695D4JRAE(P01D$5\\^._V6?"'B&:?4/"EY)X:OI"6,"KYMJS?[F04_P"
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M+^*&N-\1/BRGBC5#<:%X69I;:%844PQJTN0" "QP@')->9^$M!T=_C[X<O\
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>K6QTJ)XPBX.[?N R<XQBNZK!MKW4R;L****D1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lxrp_s8img1.jpg
<TEXT>
begin 644 lxrp_s8img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #; 9\# 2(  A$! Q$!_\0
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MHH *J7LT=K8S7$C!(XD+LQZ*!R35K('7BL'Q6K2>"M<CC4L[6$ZJJC))\MN
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MTE[W53J$D?[F @JQY#.1_3K]:]AR% 7%>AE>'Y(N4CR\SKJ=11B24N*3<O\
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M?+QS/'U]\U[)\//'UI\2O!@\2:;8W%C%YSP".9@6W(<$DCM7YJ?P'Z&ON_\
M99./@:#R3]ON.G^]55:2A"X'0_$SXQ>&_A?:QPZEOOM5F7=!86Y&\K_>;/"K
MGOUKYWU/]K+Q]<W#'3=$TRSB _U; RD>Y)]J^@/BQ\)=*^)FCA75;;6;96:S
MO47E<_P-ZH3^*\U\Y^&OV7_'6KI)+KUS!H,:2F-5E5I';'!8!3PI[9_2G2]E
MR^\!<TO]K+QW;N#J6D:7?0YY 5HF'TVU] _"[XV>&_B<6L[96T[68DWO93."
M67^]&1]Y?7N*^1?BE\'=?^%XL[F[OK?4["[8HEU A0B0<[64_=X(Y[XKB_".
MOW?A?QGH_B"Q<QS6-PLF%)!*;OFC/J",C\:WE1ISC>('ZF9'K2U3MW,D:R@8
M#J"/Q&?YU<KS.MB1:.U%%,#-N+6.YMGAEC#(P((89&#U7Z5\Y>/OA_=>'KJ7
M5-)A:33)&RP7K;[NH/JI[>E?3.&R*IS6\=S"T4D6]2NUE*YQGKG/!J9Q4D>A
M@\9/#3YH['QY&X&W)Q]:T(6^[BO2_&GPIDMWDU#P['O3.Y[3W]4/_LIKS$*]
MN[Q7$9C:-\.C\%37EU:<HGW>%S"GB(W6YIPM6A$W2LJ$GTJ_$37GSB=E34ZS
MPYKDNCZ@)=Q:VDP)8S_$.Y'H17K[1V6LV"LT:302*&!QD-Z5X)$W*UZ/\/\
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M\$?CEX+^'WP[&@Z__:1N_M,MQBWM]Z[6Q@=1Z5Z<?VK_ (8J"?+U<X[?9/\
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MGM6=2O[31@?G_P#'3X@WWQ#\9R0V$-R=!TPF.T0(P$A)P\K#'<\#T%<A\/\
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MBGT45(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4'I10>E !1244 +1244 +1244 +1
M244 +VJD\6[Y#%N4\'(R /QZU<HH B5> NW&/RJ:DHH 6BDHH 6BDHH 6BDH
MH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDH
EH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6@]*2B@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
